In mythology unicorns are skittish things, and in business they appear little easier to pin down. EP Vantage has compiled a list of private start-up companies in the healthcare arena that are widely considered to be worth more than $1bn; notably it features very few makers of human therapeutics. Instead these unicorns are involved in cutting-edge computational research such as artificial intelligence, sequencing or virtual reality, or are in risky, unproven areas. It is plausible that one of the reasons they have not been bought is because no acquirer knows where to put them (see table below). Those that are in the business of developing human therapeutics are working in the as-yet unproven field of mRNA - Moderna Therapeutics and Curevac.
The social change-driven organization Games for Change is expanding from video games into virtual reality with the VR for Change Summit at its annual Games for Change Festival this year, featuring VR projects that impact the way we learn and shape the way we view the world. The VR for Change Summit is focusing entirely on virtual reality, augmented reality, and mixed reality projects. The Games for Change Festival is happening July 31 to Aug. 2 at the New School in New York City. Susanna Pollack, president of Games for Change, said that while the organization has included some VR games in the past, the recent development of VR and its potential for positive social change led Games for Change to take a deeper look at VR this year. "We feel that Games for Change is very well-positioned to help develop this community in the same way that we have in the games community," Pollack said.
Elon Musk has said that there is only a "billions in one" chance that we're not living in a computer simulation. Our lives are almost certainly being conducted within an artificial world powered by AI and highly-powered computers, like in The Matrix, the Tesla and SpaceX CEO suggested at a tech conference in California. Mr Musk, who has donated huge amounts of money to research into the dangers of artificial intelligence, said that he hopes his prediction is true because otherwise it means the world will end. Boston Dynamics describes itself as'building dynamic robots and software for human simulation'. It has created robots for DARPA, the US' military research company Deep Blue, a computer created by IBM, won a match against world champion Garry Kasparov in 1997.
SAN ANTONIO--In the warzones of the future, medics touching down amid heavy battlefield casualties will know who to treat first, how to approach every injury, and even who is most likely to live or die -- all before looking at a single wounded soldier. That's the vision of Col. (and Dr.) Jerome Buller, who leads the U.S. Army Institute of Surgical Research. Buller says biometric data gleaned from soldier-borne sensors, combined with in-depth medical and training data and augmented reality lenses, will help medics in combat evaluate the battlefield and everyone in it from a safe distance. They will make their most important decisions before even seeing their patients. "Imagine that [the hypothetical future] medic is able to scan the battlefield and instead of seeing rubble, he's seeing red or green dots, or amber dots, and he knows where to apply resources or not," Buller said during the Defense One and NextGov Genius Machines event here on Wednesday.
The surgery requires the implant in the eye of a device, roughly the size of a grain of rice, that continuously releases a drug for the treatment of the disease. If the device in the clinical trial is approved by the Food and Drug Administration in a few years, Genentech expects to train the more than 2,200 retinal specialists in the U.S. Virtual reality will be a major component of that training in order for them to master the procedure, the company said. "Historically, surgeons had to learn on patients. What we're trying to do here is see all the possible permutations that can occur, in virtual reality, so that when [the surgeons] are actually doing this on a patient, they're ready," said Anthony Adamis, senior vice president of development innovation for Genentech. In virtual reality, users wear headsets in which they can see digitized representations of the real world.